On ECHEMI
Home > Drugs > Avanc Pharmaceutical Co., Ltd.
Avanc Pharmaceutical Co., Ltd.
  • Founded in:

    2002-01-28
  • Country:

    China China
  • Address:

    No. 55, Songshan Street, Taihe District, Jinzhou City, Liaoning Province
  • Tax NO.:

    91210700734224812X
  • Registered Funds:

    660 million yuan
  • Website:

  • Email:

Related Drugs
Asarone injection
2,4,5-Trimethoxy-1-propenylbenzene
Name Description Content CAS NO. Registered Holders
BETA-ASARONE

It antagonizes histamine and acetylcholine, relieves bronchospasm and has an anti-asthmatic effect; it has a strong inhibitory effect on the cough center; it causes increased secretions, thins thick sputum, reduces sputum viscosity, and makes it easier to cough up; it has a similar effect to aminophylline in relaxing bronchial smooth muscles; it increases the electrical stimulation threshold of the cerebral cortex, inhibits synaptic conduction of electrical stimulation and the spread of epileptic electricity.

More

It antagonizes histamine and acetylcholine, relieves bronchospasm and has an anti-asthmatic effect; it has a strong inhibitory effect on the cough center; it causes increased secretions, thins thick sputum, reduces sputum viscosity, and makes it easier to cough up; it has a similar effect to aminophylline in relaxing bronchial smooth muscles; it increases the electrical stimulation threshold of the cerebral cortex, inhibits synaptic conduction of electrical stimulation and the spread of epileptic electricity.

5273-86-9 0
Ephedrine Diphenhydramine Tablets
This product is a compound preparation, each tablet containing 25 mg of ephedrine hydrochloride and 25 mg of diphenhydramine hydrochloride.
Name Description Content CAS NO. Registered Holders
Ephedrine hydrochloride

It can directly stimulate adrenaline receptors, and can also indirectly stimulate adrenaline receptors by prompting adrenaline nerve endings to release norepinephrine. It has a stimulating effect on both alpha and beta receptors. It can dilate bronchi and constrict local blood vessels, and its action time is longer; it strengthens myocardial contractility, increases cardiac output, and makes venous return to the heart sufficient; it has a stronger central nervous system stimulating effect than adrenaline.

More

It can directly stimulate adrenaline receptors, and can also indirectly stimulate adrenaline receptors by prompting adrenaline nerve endings to release norepinephrine. It has a stimulating effect on both alpha and beta receptors. It can dilate bronchi and constrict local blood vessels, and its action time is longer; it strengthens myocardial contractility, increases cardiac output, and makes venous return to the heart sufficient; it has a stronger central nervous system stimulating effect than adrenaline.

25mg 0
Diphenhydramine Hydrochloride

It has ① antihistamine effect, which can compete with histamine released from tissues for H1 receptors on effector cells, thereby stopping allergic reactions; ② at the same time, it inhibits central nervous system activity and causes sedative and hypnotic effects; ③ it enhances the effect of antitussive drugs.

More

It has ① antihistamine effect, which can compete with histamine released from tissues for H1 receptors on effector cells, thereby stopping allergic reactions; ② at the same time, it inhibits central nervous system activity and causes sedative and hypnotic effects; ③ it enhances the effect of antitussive drugs.

25mg 147-24-0 31
Glutamine
Name Description Content CAS NO. Registered Holders
Boc-D-Glutamine

Extract from the above information

More

Extract from the above information

61348-28-5 7
Dobutamine Hydrochloride Injection
The main ingredients and chemical name of this product are: 4-[2-[[1-methyl-3-(4-hydroxyphenyl)propyl]amino]ethyl]-1,2-benzenediol hydrochloride. Molecular formula: C18H23NO3HCl Molecular weight: 337.85
Name Description Content CAS NO. Registered Holders
4-[2-[[1-methyl-3-(4-hydroxyphenyl)propyl]amino]ethyl]-1,2-benzenediol hydrochloride

1. It has a positive inotropic effect on the myocardium, mainly acting on beta 1 receptors, and has relatively little effect on beta 2 and alpha receptors; 2. It can directly excite cardiac beta 1 receptors to enhance myocardial contraction and increase stroke volume, thereby increasing cardiac output; 3. It can reduce peripheral vascular resistance (reduced afterload), but systolic blood pressure and pulse pressure generally remain unchanged, or only increase due to increased cardiac output; 4. It can reduce ventricular filling pressure and promote atrioventricular node conduction; 5. Myocardial contractility is enhanced, and coronary blood flow and myocardial oxygen consumption often increase; 6. Due to increased cardiac output, renal blood flow and urine volume often increase; 7. Unlike dopamine, dobutamine does not act indirectly through the release of endogenous norepinephrine, but directly on the heart.

More

1. It has a positive inotropic effect on the myocardium, mainly acting on beta 1 receptors, and has relatively little effect on beta 2 and alpha receptors; 2. It can directly excite cardiac beta 1 receptors to enhance myocardial contraction and increase stroke volume, thereby increasing cardiac output; 3. It can reduce peripheral vascular resistance (reduced afterload), but systolic blood pressure and pulse pressure generally remain unchanged, or only increase due to increased cardiac output; 4. It can reduce ventricular filling pressure and promote atrioventricular node conduction; 5. Myocardial contractility is enhanced, and coronary blood flow and myocardial oxygen consumption often increase; 6. Due to increased cardiac output, renal blood flow and urine volume often increase; 7. Unlike dopamine, dobutamine does not act indirectly through the release of endogenous norepinephrine, but directly on the heart.

0
Norfloxacin Glutamate Injection
Name Description Content CAS NO. Registered Holders
Norfloxacin glutamic acid

No specific pharmacological effects mentioned

More

No specific pharmacological effects mentioned

0
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.